Registration and Agenda Information
Neglected Infectious Diseases and Public Private Partnerships:
What Works, What Doesn't, What's Next?
A symposium sponsored by Harvard School of Public Health's Unfinished Agenda of Infectious Diseases Executive Committee
October 15, 2009 8 a.m.-2 p.m.
Harvard Club | Downtown Boston
One Federal Street
38th floor Boston, MA
For more information and to register, contact:
Anna Cembrola, 617-998-8818
Agenda
8:00-8:45 a.m. Breakfast
8:45-9:00 a.m. Welcome and Opening Remarks
* Dyann Wirth, Chair, Department of Immunology and Infectious Diseases, Richard Pearson Strong Professor of Infectious Diseases
Harvard School of Public Health
9:00-10:15 a.m. Keynote
* Jim Thompson, Deputy Director, Global Partnership Initiative, U.S. Department of State
10:15-10:30 Break
10:30-11:45 Panel: Success Stories in Partnerships
* Steven Phillips, ExxonMobil Medical Director of Global Issues and Projects (speaking on malaria)
* Chris Walker, philanthropist (speaking on tuberculosis)
* Martin Springsklee Vice President, Head Global Medical Affairs (Anti-Infectives/Men's Health Group), Bayer Schering Pharma AG (speaking on Chagas and other neglected diseases)
12:00-1:00 p.m. Panel: Future Opportunities for Public-Private Partnerships
* Garry Neill, Vice President, Corporate Office of Science and Technology, and Chief Scientific Officer, Johnson & Johnson
* Ilze Melngailis, Vice President, Partnerships and Impact Initiatives, Global Business Coalition
* Eric Rubin, Professor of Immunology and Infectious Diseases, Harvard School of Public Health
* Lydia Pan, Sr. Principal Scientist, Pfizer
1:00- 2:00 p.m. Closing Remarks; networking lunch
* David Scheer, President, Scheer & Company, Inc.; Chair, Executive Commitee, the Unfinished Agenda of Infectious Diseases
|
|
|
|
|
|
